Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cytosorbents (CTSO) Non-cash Items (2019 - 2025)

Cytosorbents (CTSO) has disclosed Non-cash Items for 7 consecutive years, with $4.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Non-cash Items fell 100.0% year-over-year to $4.0, compared with a TTM value of $4.0 through Sep 2025, down 100.0%, and an annual FY2024 reading of $3.0 million, down 37.65% over the prior year.
  • Non-cash Items was $4.0 for Q3 2025 at Cytosorbents, down from $1064.0 in the prior quarter.
  • Across five years, Non-cash Items topped out at $8.0 million in Q3 2023 and bottomed at $4.0 in Q3 2025.
  • Average Non-cash Items over 5 years is $4.2 million, with a median of $4.1 million recorded in 2022.
  • The sharpest move saw Non-cash Items soared 60.61% in 2021, then plummeted 100.0% in 2025.
  • Year by year, Non-cash Items stood at $5.9 million in 2021, then plummeted by 34.54% to $3.9 million in 2022, then increased by 25.37% to $4.9 million in 2023, then tumbled by 37.65% to $3.0 million in 2024, then plummeted by 100.0% to $4.0 in 2025.
  • Business Quant data shows Non-cash Items for CTSO at $4.0 in Q3 2025, $1064.0 in Q2 2025, and $2.3 million in Q1 2025.